HK13984A - A process for the preparation of 1,3,7-trialkylxanthines and 1-isopropyl-3,7-dimethylxanthine as medicaments - Google Patents

A process for the preparation of 1,3,7-trialkylxanthines and 1-isopropyl-3,7-dimethylxanthine as medicaments

Info

Publication number
HK13984A
HK13984A HK139/84A HK13984A HK13984A HK 13984 A HK13984 A HK 13984A HK 139/84 A HK139/84 A HK 139/84A HK 13984 A HK13984 A HK 13984A HK 13984 A HK13984 A HK 13984A
Authority
HK
Hong Kong
Prior art keywords
trialkylxanthines
dimethylxanthine
medicaments
isopropyl
preparation
Prior art date
Application number
HK139/84A
Other languages
English (en)
Inventor
Marc Enslen
Georges Philippossian
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of HK13984A publication Critical patent/HK13984A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK139/84A 1979-05-22 1984-02-16 A process for the preparation of 1,3,7-trialkylxanthines and 1-isopropyl-3,7-dimethylxanthine as medicaments HK13984A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4780/79A CH654008A5 (fr) 1979-05-22 1979-05-22 Procede de preparation de 1,3,7-trialkylxanthines.

Publications (1)

Publication Number Publication Date
HK13984A true HK13984A (en) 1984-02-24

Family

ID=4282410

Family Applications (1)

Application Number Title Priority Date Filing Date
HK139/84A HK13984A (en) 1979-05-22 1984-02-16 A process for the preparation of 1,3,7-trialkylxanthines and 1-isopropyl-3,7-dimethylxanthine as medicaments

Country Status (13)

Country Link
US (2) US4299833A (es)
EP (1) EP0019165B1 (es)
JP (2) JPS55154973A (es)
CH (1) CH654008A5 (es)
DE (1) DE3070919D1 (es)
ES (1) ES491683A0 (es)
GB (1) GB2052480B (es)
HK (1) HK13984A (es)
HU (1) HU184280B (es)
IL (1) IL60025A (es)
MY (1) MY8400259A (es)
PH (1) PH17503A (es)
SG (1) SG29483G (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH643260A5 (fr) * 1980-05-02 1984-05-30 Nestle Sa 1-allyl-3-butyl-8-methylxanthine, procede de preparation et utilisation dans un medicament.
IT1200944B (it) * 1982-08-10 1989-01-27 Malesci Sas Derivati xantinici,procedimento per la loro preparazione,composizione farmaceutiche che il contengono e loro impiego terapeutico
EP0262344B1 (de) * 1986-08-07 1996-03-27 MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG N-alkylierte quartäre stickstoffhaltige Heterozyklen, Verfahren zu deren Herstellung und deren Verwendung in Arzneimitteln
GB8906792D0 (en) * 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds
NZ240644A (en) * 1990-11-21 1994-08-26 Smithkline Beecham Corp Use of xanthine derivatives to inhibit the production of tumour necrosis factor (tnf)
IT1258944B (it) * 1992-06-22 1996-03-08 Emilio Toja Derivati 7-neopentil xantinici, loro preparazione e composizioni farmaceutiche che li contengono
TW225535B (es) * 1992-11-10 1994-06-21 Hoechst Ag
EP1893614B1 (en) * 2005-06-21 2013-05-22 The University Court of the University of Dundee Inhibitor compounds
WO2008107436A1 (en) * 2007-03-06 2008-09-12 Novartis Ag Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions
CN101220032B (zh) * 2007-12-14 2010-06-02 百利高贸易（上海）有限公司 3_甲基黄嘌呤二钠盐甲化制备可可碱的新方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH4780A (fr) 1892-04-05 1892-07-30 Emile Bauer Nouveau système de machine à détente
US631757A (en) * 1898-02-18 1899-08-22 Boehringer & Soehne Xanthin derivative and process of making same.
US631760A (en) * 1898-03-04 1899-08-22 Boehringer & Soehne Alkylized xanthin and process of making same.
US2523496A (en) * 1948-10-21 1950-09-26 Kenneth N Campbell Method of preparing xanthine and methylated xanthines
GB706424A (en) * 1950-05-17 1954-03-31 Hoechst Ag Manufacture of xanthine and its alkyl derivatives
US3740433A (en) * 1971-10-01 1973-06-19 Squibb & Sons Inc Anti-anxiety composition and method of use
DE2714953C2 (de) * 1977-04-02 1986-09-25 Hoechst Ag, 6230 Frankfurt Arzneimittel

Also Published As

Publication number Publication date
EP0019165B1 (fr) 1985-07-31
GB2052480B (en) 1983-03-16
EP0019165A1 (fr) 1980-11-26
SG29483G (en) 1985-01-11
GB2052480A (en) 1981-01-28
JPS55154973A (en) 1980-12-02
IL60025A0 (en) 1980-07-31
HU184280B (en) 1984-07-30
US4299833A (en) 1981-11-10
JPH0210835B2 (es) 1990-03-09
US4450163A (en) 1984-05-22
MY8400259A (en) 1984-12-31
CH654008A5 (fr) 1986-01-31
IL60025A (en) 1984-10-31
DE3070919D1 (en) 1985-09-05
ES8104290A1 (es) 1981-04-16
PH17503A (en) 1984-09-07
JPH01199972A (ja) 1989-08-11
ES491683A0 (es) 1981-04-16

Similar Documents

Publication Publication Date Title
GB2047247B (en) 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyloxacyclopentadecane-2-one and derivatives thereof as well as processes for their preparation
DE3065026D1 (en) Phenylsulphonamide derivatives, a process for their preparation and their use as medicines
GB2107306B (en) Isothiourea and isourea derivatives and process for the preparation thereof
IL56944A (en) Process for the preparation of cis-hexahydrodibenzopyranones and 3,4,5,6-tetrahydro-2h-1-benzoxocin derivatives
GB2066812B (en) 5'-acyl-uridine derivatives and processes for the preparation thereof
DE3065868D1 (en) Sulphonamide derivatives, a process for their preparation and their use as medicines
GB2064527B (en) Moranoline derivatives and process for preparation thereof
HK13984A (en) A process for the preparation of 1,3,7-trialkylxanthines and 1-isopropyl-3,7-dimethylxanthine as medicaments
DE3063952D1 (en) Process for the preparation of riboflavin
DE3062396D1 (en) Process for the preparation of somatostatine
DE3064993D1 (en) Process for the preparation of hexahydronaphthacene derivatives
ZA804178B (en) Process for the preparation of 2,6-dialkylcyclohexylamines
DE3061152D1 (en) Pyrazoloindazole derivatives and process for preparing the same and pharmaceutical compositions
PT71582A (en) Process for the preparation of 3-methyleneazetidine derivatives
IL60588A0 (en) New halovicamone derivatives and a process for the preparation thereof
ZA802888B (en) New hydroxyamino-eburnane derivatives and a process for the preparation thereof
DE3071707D1 (en) 7-n-heterocyclyl cephalosporins, a process for preparing and a pharmaceutical composition comprising the same
GB1538705A (en) 1,4-dihydropyridine-sugar derivatives process for their preparation and their use as medicaments
PT70537A (en) Process for the preparation of 2',6'-dialkyl-n-alkoxymethyl-2-chloro-acetanilides
GB2017091B (en) Glyoxal-2-oxime derivatives and a process for the preparation thereof
IL60827A0 (en) 10-halogen-e-homo eburnanes and a process for the preparation thereof
ZA805370B (en) 1,2,4-triglycidyl triazolidine-3,5-diones and a process for the preparation thereof
PH15654A (en) A process for the preparation of 15-hydroxyimino-e-homoeburnane derivatives
GB2048256B (en) Aminoisoquinoline derivatives and a process for the preparation thereof
IL60587A0 (en) New halogenated 15-hydroxy-e-homoeburnane derivatives and a process for the preparation thereof

Legal Events

Date Code Title Description
PE Patent expired